|
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Azithromycin Tablets USP, 500 mg (USRLD: Zithromax Tablets).
Azithromycin is indicated to treat certain bacterial infections such as bronchitis, pneumonia, sexually transmitted diseases (STD), infections of the ears, lungs, sinuses, skin, throat, and reproductive organs.
The drug will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad (India).
Azithromycin Tablets USP, 500 mg had annual sales of USD 20 mn in the United States (IQVIA MAT Feb. 2023).
|